Stoke Therapeutics Inc’s recent filing unveils that its CHIEF MEDICAL OFFICER Ticho Barry unloaded Company’s shares for reported $0.12 million on Oct 01 ’24. In the deal valued at $12.06 per share,10,000 shares were sold. As a result of this transaction, Ticho Barry now holds 2,485 shares worth roughly $30515.8.
Then, Skorpios Trust sold 1,937,500 shares, generating $27,221,875 in total proceeds. Upon selling the shares at $14.05, the 10% Owner now owns 8,906,181 shares.
Before that, Blue Horizon E LTD bought 1,937,500 shares. Stoke Therapeutics Inc shares valued at $29,488,750 were divested by the Affiliate at a price of $15.22 per share.
TD Cowen upgraded its Stoke Therapeutics Inc [STOK] rating to an Outperform from a a Market perform in a research note published recently. TD Cowen also remained covering STOK and has decreased its forecast on July 25, 2023 with a “Market perform” recommendation from previously “an Outperform” rating. BofA Securities revised its rating on May 01, 2023. It rated STOK as “a Neutral” which previously was an “an Underperform”.
Price Performance Review of STOK
On Tuesday, Stoke Therapeutics Inc [NASDAQ:STOK] saw its stock jump 7.72% to $12.28. Over the last five days, the stock has lost -0.73%. Stoke Therapeutics Inc shares have risen nearly 133.46% since the year began. Nevertheless, the stocks have risen 215.68% over the past one year. While a 52-week high of $17.58 was reached on 06/13/24, a 52-week low of $3.35 was recorded on 02/13/24. SMA at 50 days reached $13.97, while 200 days put it at $11.15.
Levels Of Support And Resistance For STOK Stock
The 24-hour chart illustrates a support level at 11.66, which if violated will result in even more drops to 11.04. On the upside, there is a resistance level at 12.67. A further resistance level may holdings at 13.06. The Relative Strength Index (RSI) on the 14-day chart is 41.06, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.78, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 77.40%. Stochastics %K at 12.51% indicates the stock is a buying.
How much short interest is there in Stoke Therapeutics Inc?
A steep rise in short interest was recorded in Stoke Therapeutics Inc stocks on 2024-09-13, dropping by -1.18 million shares to a total of 8.71 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 9.89 million shares. There was a decline of -13.51%, which implies that there is a negative sentiment for the stock.
